Clinical Therapeutics/New Technology-Non-Insulin Injectables

Clinical Therapeutics/New Technology-Non-Insulin Injectables

You have access
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
Juan P. Frias, Enzo Bonora, Luis Nevarez Ruiz, Ying G. Li, Zhuoxin Yu, Zvonko Milicevic, Raleigh Malik, M. Angelyn Bethel, David A. Cox

Diabetes Care Jan 2021, dc201473; DOI: 10.2337/dc20-1473
You have access
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
Christopher K. Rayner, Linda E. Watson, Liza K. Phillips, Kylie Lange, Michelle J. Bound, Jacqueline Grivell, Tongzhi Wu, Karen L. Jones, Michael Horowitz, Ele Ferrannini, Domenico Tricò, Silvia Frascerra, Andrea Mari, Andrea Natali

Diabetes Care Aug 2020, 43 (8) 1813-1821; DOI: 10.2337/dc20-0190
Open Access
Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
Geremia B. Bolli, Francesca Porcellati, Juris J. Meier

Diabetes Care Oct 2020, 43 (10) 2333-2335; DOI: 10.2337/dci20-0038
Open Access
Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis
Jessica A. Huthmacher, Juris J. Meier, Michael A. Nauck

Diabetes Care Sep 2020, 43 (9) 2303-2312; DOI: 10.2337/dc20-0498
Open Access
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
Matthew J. Crowley, Darren K. McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A. Saevereid, Subodh Verma, John B. Buse

Diabetes Care Sep 2020, 43 (9) e108-e110; DOI: 10.2337/dc20-0437
Open Access
GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
Alexander S. Christensen, Sofie Hædersdal, Heidi Storgaard, Kathrine Rose, Nina L. Hansen, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll

Diabetes Sep 2020, 69 (9) 1989-2002; DOI: 10.2337/db20-0074
You have access
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR_Rx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy
Erin S. Morgan, Li-Jung Tai, Nguyen C. Pham, Julia K. Overman, Lynnetta M. Watts, Anne Smith, Shiangtung W. Jung, Martin Gajdošík, Martin Krššák, Michael Krebs, Richard S. Geary, Brenda F. Baker, Sanjay Bhanot

Diabetes Care Apr 2019, 42 (4) 585-593; DOI: 10.2337/dc18-1343
Open Access
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
Mark L. Hartman, Arun J. Sanyal, Rohit Loomba, Jonathan M. Wilson, Amir Nikooienejad, Ross Bray, Chrisanthi A. Karanikas, Kevin L. Duffin, Deborah A. Robins, Axel Haupt

Diabetes Care Jun 2020, 43 (6) 1352-1355; DOI: 10.2337/dc19-1892
You have access
Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
The RISE Consortium

Diabetes Care Sep 2019, 42 (9) 1742-1751; DOI: 10.2337/dc19-0556
You have access
A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Maya Fayfman, Rodolfo J. Galindo, Daniel J. Rubin, Dara L. Mize, Isabel Anzola, Maria A. Urrutia, Clementina Ramos, Francisco J. Pasquel, J. Sonya Haw, Priyathama Vellanki, Heqiong Wang, Bonnie S. Albury, Rita Weaver, Saumeth Cardona, Guillermo E. Umpierrez

Diabetes Care Mar 2019, 42 (3) 450-456; DOI: 10.2337/dc18-1760

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Non-Insulin Injectables

Pages

Navigation

Information

ADA Journals

Other ADA Resources